Skip to main content
. 2024 Nov 15;11:1465280. doi: 10.3389/fmed.2024.1465280

Table 1.

Schedule of enrollment, assessments, and interventions.

Item Study period
Enrollment Allocation Post-allocation Close-out
Time point (week) −4–0 0 1–12 12–24
Enrolment
Eligibility screen
Informed consent ×
Inclusion/exclusion ×
Randomization ×
Allocation ×
Intervention
BTG plus standard treatment ×
Standard treatment ×
Assessment
PFS × ×
Quality of life scores × ×
Overall survival × ×
Objective response rate × ×
Liver-specific PFS × ×
Disease control rate × ×
TCM syndrome score × ×
Piper Fatigue Scale × ×
KPS × ×
Adverse events × ×
Compliance evaluation ×
Acceptability evaluation ×

BTG, Buzhong Tiaogan granule; TCM, Traditional Chinese Medicine; KPS, Karnofsky performance score; PFS, Progression-free survival.